Overall interleukin-6 production exceeds 7 mg/day in multiple myeloma complicated by sepsis

This publication has 10 references indexed in Scilit:

• High amounts of circulating interleukin (IL)‐6 in the form of monomeric immune complexes during anti‐IL‐6 therapy. Towards a new methodology for measuring overall cytokine production in human in vivo
  European Journal of Immunology, 1992
• Human recombinant dimeric IL-6 binds to its receptor as detected by anti-IL-6 monoclonal antibodies
  Molecular Immunology, 1991
• Murine anti-interleukin-6 monoclonal antibody therapy for a patient with plasma cell leukemia
  Blood, 1991
• Molecular cloning and expression of an IL-6 signal transducer, gp130
  Cell, 1990
• Acute-phase response of human hepatocytes: Regulation of acute-phase protein synthesis by interleukin-6
  Hepatology, 1990
• Serum levels of interleukin 6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias.
  Journal of Clinical Investigation, 1989
• Multiple forms of IFN-beta 2/IL-6 in serum and body fluids during acute bacterial infection.
  The Journal of Immunology, 1989
• Genes coding for RNA polymerase β subunit in bacteria
  European Journal of Biochemistry, 1988
• Interleukin‐6 in synovial fluid and serum of patients with rheumatoid arthritis and other inflammatory arthritides
  Arthritis & Rheumatism, 1988
• Stable model immune complexes produced by bivalent affinity labeling haptens: In-vivo survival
  Molecular Immunology, 1979